Deutsche Bank Downgrades MedAssets (MDAS) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink Swann Downgrades MedAssets (MDAS) to Market Perform
February 18, 2015 7:24 AM ESTLeerink Swann downgraded MedAssets (NASDAQ: MDAS) from Outperform to Market Perform with a price target of $18.00 (from $26.00).
For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.
Shares of MedAssets closed at $19.83 yesterday.
... MoreMedAssets (MDAS) Reports In-Line Q4 EPS, FY15 EPS Guidance Misses
February 17, 2015 4:50 PM ESTMedAssets (NASDAQ: MDAS) reported Q4 EPS of $0.39, in-line with the analyst estimate of $0.39. Revenue for the quarter came in at $198.2 million versus the consensus estimate of $195.3 million.
MedAssets sees FY2015 EPS of $1.13-$1.23, versus the consensus of $1.45. MedAssets sees FY2015 revenue of $753-767... More
